An observational study in HIV-1-infection and Sexually Transmitted Diseases, sponsored by Hospital Universitario Infanta Leonor. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2023-08-21.
Sponsored by Hospital Universitario Infanta Leonor · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Sexually Transmitted Diseases with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Sexually Transmitted Diseases · Spain.
Among the 12 studies in Sexually Transmitted Diseases with a site in Spain, this one is one of 2 that started in 2022, is one of 6 observational ones, and was the 9th registered.
525 studies on the registry are indexed under Sexually Transmitted Diseases; 79 are open to participants now.
Browse Sexually Transmitted Diseases studies →4 of the 12 studies in Sexually Transmitted Diseases with a site in Spain are open now. Recruiting first, the newest first:
Parc de Salut Mar · Sites in Spain
Ages 18–25
Hospital Universitario de Valme · Sites in Spain
Ages 16+ · Healthy volunteers
Hospitales Universitarios Virgen del Rocío · Sites in Spain
Ages 18+ · Healthy volunteers
University of Seville · Sites in Spain
Ages 11–14 · Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 49 Sexually Transmitted Diseases studies recruiting now, 30 (61%) set no upper age limit and 17 (35%) stop at 75 or younger; 23 take children under 18; 33 take healthy volunteers.
This study: all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3
First in 2010; this study’s year is marked. 2 started in 2022.
This study's enrollment of 631 is close to the median of 578 across 93 observational studies indexed under Sexually Transmitted Diseases.
Median enrollment 713 across the 6 interventional studies, 766 across the 6 observational. Of the 5 that completed or were terminated, 3 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 12 have an industry lead sponsor. The 10 most frequent:
Hospital Universitario Infanta Leonor is the lead sponsor of 12 studies on the registry; 1 is open to participants now.
Hospital Universitario Infanta Leonor has 1 study filed under Sexually Transmitted Diseases — fewer than ten, so there is no comparison to draw.
2 of the studies in Sexually Transmitted Diseases with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07846241Parc de Salut MarSexual Behavior and Risk Perception as Factors Associated With STI Incidence in Young Adults | 2027-01-15 |
| NCT07208045University of SevilleCultural Adaptation, Validation, and Evaluation of the Programme for Promotion of Healthy Affective-Sexual Behaviours in Adolescents (IYG) | 2027-06-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 12 studies in Sexually Transmitted Diseases with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a longitudinal observational study conducted in Europe that describes migrants infected with HIV from Latin America who come to Europe with the intention of seeking asylum or international protection. The aim of the study is to identify the barriers this population faces in accessing the healthcare system and to assess disease control
Study Design and Setting This observational study was conducted between 2022 and 2023 in Madrid, Spain. Participants were recruited at the HIV outpatient clinic of Infanta Leonor University Hospital (HUIL) for the study and were monitored for a period of 6 months from their enrollment in the study.
Participant Recruitment Participants were primarily identified and referred by various non-governmental organizations (NGOs) working with migrants living with HIV. These NGOs, which included gTt-VIH, Apoyo Positivo, Cogam, Acción Triangulo, Kif-Kif, Salud Entre Culturas, and the Spanish Red Cross, played an essential role by establishing a crucial link and provided a vital bridge, facilitating the patients' integration into the healthcare system through an unconventional circuit.
Medical Evaluation In the HIV unit, assessments were conducted by experienced infectious disease specialists and a unit-specific nurse. The care protocol comprised a meticulous collection of medical history, an exhaustive physical examination, along with a series of tests. Furthermore, appointments were scheduled for a one-month and six-month follow-up to ensure continuous care and monitor the effectiveness of the treatment regimen.
Social and Psychological Evaluation An experienced social worker with a background in vulnerable populations was hired to perform a social assessment. Six months post the initial hospital visit, the social worker re-established contact with the patients to reassess their social circumstances and their continued engagement with the HIV consultation services.
Ethical Considerations This study adhered to the ethical principles outlined in the Declaration of Helsinki and received the necessary approvals from the ethics committee at Infanta Leonor Hospital. Informed consent was provided by every participant.
Data collection In this study, the REDCap application was utilized for the collection of data. The database was stored in a secure server, and only researchers and health personnel of the project had access to it.
Latin American migrants infected with HIV
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cohort of Latin American migrants living with HIV who were seeking international protection in Spain (Europe)
Other: Description
This study aimed to understand the situation of Latin American HIV-positive migrants seeking asylum in Spain and identify the challenges they encounter in getting HIV treatment. The main result measured was the proportion of participants with an HIV-1 RNA level of 50 copies/mL or higher at their first clinic visit
HIV viral control
Number of participants with plasma HIV-1 RNA level of more than 50 copies per mL
Time frame: At inclusion
Resistance Pattern
Number of participants with Drug Resistance
Time frame: At inclusion
Sexually transmited infections
Number of participants with sexually transmited infections
Time frame: At inclusion
Number and Type of Barriers to Accessing Healthcare
The outcome will assess the number and type of barriers faced by study participants when trying to access healthcare, based on the presence of any of the following barriers: administrative, geographical, financial, cultural, lack of knowledge, stigma, and organizational.
Time frame: At inclusion
HIV viral control at 6 months
Number of participants with plasma HIV-1 RNA level of more than 50 copies per mL
Time frame: 6 months
Retention in care
Number of participants who maintain retention to healthcare
Time frame: 6 months
Plan to share: Yes — IPD that underlie results in a publication
Supporting information: Study protocol
Time frame: December, 2024
Access criteria: IP email
No publications or documents are linked to this record.
Ran from Jan 2022 to primary completion in Apr 2023, 15 months.
Of 42 non-industry observational studies under Sexually Transmitted Diseases, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 57. This study's 15 months is below that.
Counting every sponsor, half of 48 studies reached it within 26 months; a quarter within 15 and three quarters within 49.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sexually Transmitted Diseases →
Hospital Universitario Infanta Leonor